Osteoporosis, Osteopenia
24
1
2
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
17%
4 trials in Phase 3/4
12%
2 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (24)
Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength
A Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older
Protocol Optimization in CT for the Quantification of BMD
Long-term Effect of Steroid on Metabolic Diseases in Asthmatics
Bone Properties Following Exercise Induced Changes in Insulin Sensitivity in People With Type 2 Diabetes
Fall, Fracture and Frailty
Functional Exercise and Nutrition Education Program for Older Adults
Effect of Pitavastatin on Bone
Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men
Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass
Alendronate Versus Denosumab in Kidney Transplant Patients
Effect of Soy Phytoestrogens and Acupuncture on Bone Mineral Density in Female Athlete Triad at Adolescence Age
Sarcopenia and Osteoporosis in the Patients With Hemophilia
Osteosarcopenia and Exercise
Effects of Vitamin D Supplementation in Muscle Strength and Balance Training
Effects of Jumping on Bone Health in Young Women
Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis
µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis